Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.
Wobble Genomics has raised $10.9M in total funding. The most recent round was Seed. The last funding was announced in March 2024.
Wobble Genomics's investors include IQ Capital, Eos, Business Growth Fund, Mercia Ventures, Scottish Enterprise.
Wobble Genomics is headquartered in Edinburgh, United Kingdom.
Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.
Wobble Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Wobble Genomics — Funding & Investors." VCBacked, March 7, 2024, https://www.vcbacked.co/company/wobble-genomics. Accessed July 20, 2026.
VCBacked. (2024). Wobble Genomics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/wobble-genomics
{{cite web |title=Wobble Genomics — Funding & Investors |url=https://www.vcbacked.co/company/wobble-genomics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated